Axonics Modulation Technologies logo
Axonics Modulation Technologies AXNX

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Axonics Modulation Technologies Balance Sheet 2011-2025 | AXNX

Annual Balance Sheet Axonics Modulation Technologies

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-230 M -210 M -220 M -138 M -19.6 M -24.3 M -7.91 M - - - - -

Long Term Debt

7.56 M 9.05 M 19.8 M 20.3 M 19.5 M - - - - - - -

Long Term Debt Current

1.56 M 1.37 M 1.28 M 602 K 768 K - - - - - - -

Total Non Current Liabilities

- - - 24.8 M 22.7 M 93.4 M 58.8 M - - - - -

Total Current Liabilities

65.2 M 26.9 M 45.7 M 12 M 5.89 M - - - - - - -

Total Liabilities

89.2 M 65.5 M 54.8 M 36.8 M 28.6 M 95.8 M 60.3 M - - - - -

Retained Earnings

-374 M -315 M -234 M -180 M -99.6 M -67.2 M -49.1 M - - - - -

Total Assets

659 M 548 M 342 M 220 M 172 M 29.4 M 10.9 M - - - - -

Cash and Cash Equivalents

239 M 221 M 241 M 171 M 98.3 M 24.4 M - - - - - -

Book Value

570 M 482 M 287 M 183 M 143 M -66.4 M -49.4 M - - - - -

Total Shareholders Equity

570 M 482 M 287 M 183 M 143 M -66.4 M - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Axonics Modulation Technologies

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - 25.8 M - - - 7.56 M - - - 9.05 M 109 K 89 K 75.2 M - 5.93 M 10.8 M - 20.3 M 20.3 M 20.3 M 20.3 M 19.5 M 19.5 M 19.5 M 19.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

110 M 104 M 88.5 M 82.4 M - 48.5 M - 89.2 M 82.8 M - 62.1 M 65.5 M 71.2 M 61.2 M 115 M 54.8 M 54.8 M 54.8 M 54.8 M 36.8 M 36.8 M 36.8 M 36.8 M 28.6 M 28.6 M 28.6 M 28.6 M 2.54 M 2.54 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-393 M -393 M -399 M -380 M - -391 M - -374 M -375 M - -337 M -315 M -299 M -282 M -257 M -234 M -234 M -234 M -234 M -180 M -180 M -180 M -180 M -99.6 M -99.6 M -99.6 M -99.6 M -67.2 M -67.2 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

774 M 747 M 716 M 720 M - 649 M - 659 M 632 M - 526 M 548 M 561 M 566 M 445 M 342 M 342 M 342 M 342 M 220 M 220 M 220 M 220 M 172 M 172 M 172 M 172 M 29.4 M 29.4 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

239 M 169 M 233 M 105 M 147 M 145 M 240 M 239 M 241 M 203 M 213 M 221 M 229 M 231 M 131 M 241 M 241 M 241 M 241 M 171 M 171 M 171 M 171 M 98.3 M 98.3 M 98.3 M 98.3 M 24.4 M 24.4 M - - 8.21 M - - - - - - - - - - - - - - - - - - - - - - -

Book Value

664 M 643 M 627 M 638 M - 601 M - 570 M 550 M - 463 M 482 M 490 M 504 M 330 M 287 M 287 M 287 M 287 M 183 M 183 M 183 M 183 M 143 M 143 M 143 M 143 M 26.9 M 26.9 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

664 M 643 M 627 M 638 M 611 M 601 M 577 M 570 M 550 M 438 M 463 M 482 M 490 M 504 M 330 M 287 M 287 M 287 M 287 M 183 M 183 M 183 M 183 M 143 M 143 M 143 M 143 M -66.4 M -66.4 M - - -49.4 M - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of Axonics Modulation Technologies, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 3.86 -3.26 % $ 134 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Abiomed Abiomed
ABMD
- - $ 17.2 B usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
$ 307.92 -1.93 % $ 8.69 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 45.13 -2.67 % $ 6.72 K usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 125.1 1.48 % $ 218 B usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 92.34 0.64 % $ 136 B usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 2.56 8.94 % $ 95.5 M franceFrance
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 0.92 -4.72 % $ 14.8 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 96.35 -1.06 % $ 1.22 B usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 17.7 -3.46 % $ 408 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
LivaNova PLC LivaNova PLC
LIVN
$ 62.79 -1.82 % $ 3.41 B britainBritain
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 2.53 0.86 % $ 99 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
InMode Ltd. InMode Ltd.
INMD
$ 14.56 0.76 % $ 1.15 B israelIsrael
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 9.88 0.05 % $ 709 M israelIsrael
Myomo Myomo
MYO
$ 1.06 -1.85 % $ 7.47 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 13.41 -4.56 % $ 1.03 B usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Align Technology Align Technology
ALGN
$ 165.15 0.78 % $ 12.4 B usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 1.07 -3.18 % $ 110 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 12.81 -1.23 % $ 346 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 15.51 -1.27 % $ 591 M curacaoCuracao
FONAR Corporation FONAR Corporation
FONR
$ 14.86 -0.03 % $ 97.4 M usaUSA
AxoGen AxoGen
AXGN
$ 30.33 1.15 % $ 1.34 B usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 40.78 2.33 % $ 1.26 B usaUSA
LENSAR LENSAR
LNSR
$ 11.48 -0.17 % $ 132 M usaUSA